Hemostemix Inc. announced its study of NCP-01 supporting brain computer interfaces has been submitted for peer review publication. Mitigating challenges Facing Clinical Applications of Implantable Biosensors Supporting Brain Computer Interfaces is co-authored by Dr. Chris McNorgan, Dr. Fraser C. Henderson, Sr., Dr. Ina Sarel, Dr. Ken Webb, Dr. Jeong Soo Lee. Within the last two decades, advances in neurological medicine have led to the development of implantable electrodes for deep brain stimulation that have been used over 160,000 times since their introduction.

Coupled to brain-computer interfaces, these devices restore mobility on a limited basis. The safe implantation and reliable long-term performance of implantable devices is critical to their effectiveness. The study describes the scientific bases of how NCP-01 (NCP) leverages the patient's innate signalling processes to migrate to and engraft at the site of implantation, and trigger the factors that improve signal uptake and sensing.

NCP injections over time will likely improve the performance and longevity of implants by months and years, decreasing the need for replacement electrodes.